Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 538970Generated: November 1, 2026

Sulfuric Acid → 2-Cyanophenylboronic acid

https://huagongshe.com/reaction/538970

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSulfuric AcidHCID 1118—
ReactantBenzonitrileHCID 7505—
Reactant2,2,6,6-TetramethylpiperidineHCID 13035—
ReactantTriisopropyl borateHCID 21531—
ReactantButyllithiumHCID 178418339—
ReactantHCID 178418821HCID 178418821—
SolventTetrahydrofuranHCID 8028—
SolventHexaneHCID 8058—
SolventEthyl AcetateHCID 8857—
Product2-Cyanophenylboronic acidHCID 273461031.7%

Reaction Conditions

Temperature-78 °C

Reaction Steps

In a 300 ml nitrogen-substituted flask, 21.6 g (0.153 mol) of 2,2,6,6-tetramethylpiperidine was dissolved in 130 ml of THF. Then, to the resulting solution, 96 ml (0.153 mol) of a 15% solution of n-butyllithium in hexane was added dropwise at −10° C. to prepare lithium 2,2,6,6-tetramethylpiperidide. This solution was cooled to −78° C., and then 67 ml (0.291 mol) of triisopropoxyborane was added dropwise thereto. Next, 15 g (0.146 mol) of benzonitrile was added dropwise, and then the resulting solution was aged for 2 hours at the same temperature. The temperature of the reaction solution was increased to room temperature, and then the solution was hydrolyzed by 230 ml of 2N H2SO4. The solution was charged with 150 ml of ethyl acetate and stirred, and then the acid phase (pH<1) was separated. The aqueous phase was extracted with 100 ml of ethyl acetate. Then, the two organic phases were mixed and washed with 90 ml of saturated brine. The resulting organic phase was then dried with anhydrous magnesium sulfate and concentrated using an evaporator. The concentrated solution was charged with 100 ml of dichloromethane, and then the solution was charged with 50 ml of hexane at 0° C. The precipitated crystals were filtered and dried to obtain 6.8 g of 2-cyanophenylboronic acid crystals. The purity of the 2-cyanophenylboronic acid was 98.5%, in which 0.4 mol % of 1-phenyl-1-(2,2,6,6-tetramethylpiperidin-1-yl)methyl imine was included.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08865942B2
Source datasetuspto-grants-2014_10
ORD IDord-ced606be451c42c699704a82b116b415
Source noteuspto-grants-2014_10